We, Chemical Resources are the Finalist of CPHI Pharma Awards 2022 for
CHERESO continued its successful presence as an exhibitor at CPhI- Worldwide which
Exhibited at Vitafoods- Europe 2022 after a long period with full enthusiasm & fantastic
We have been granted the following Patents for ‘A Single herb extract for the treatment
It is an immense pleasure to share this news that our Research
Fenfuro abstract title: Clinical study to determine efficacy of trigonella foenum-graecum extract
TEAM FENFURO participated in BPCON 2013 – 23rd annual meeting of Indian society for Hypertension
1. Society of Toxicology SOT 2014, Phoenix, AZ March 24, 2014, 9:30
TEAM FENFURO participated in 6th World Ayurveda Congress & Arogya held at
TEAM FENFURO partcipated in Ninth Edition of PHD Chamber’s Annual International Trade
Team FENFURO participated in VIBRANT GUJARAT GLOBAL TRADE SHOW – 2015 held at The Exhibition
Poster Presented on “Clinical evaluation of Standardized Fenugreek seed extract as Furostanolic
Hon’able Sh.Nitin Gadkari, Union Transport and Highways Minister visited our stall at
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH
Our company has been declared a WINNER in overall evaluation for INDIA
Patients with type 2 diabetes treated with insulin could be exposed to
Enlarged prostate gland is a common problem in the ageing males. It
We have exhibited in Vitafoods Asiaworld-Expo,Hong Kong on 1-2 September’ 2016 & we
TEAM FENFURO participated in Vitafoods Europe 2017 at Palexpo Geneva, Switzerland from 9 –
Our company has been awarded ‘AIMA – Dr. J S Juneja’ for
We had exhibited in Vitafoods Europe from 15 – 17 May, 2018 at Palexpo,
Another feather in a cap! We have been #awarded for ‘Patent portfolio
We Will exhibit at CPhI Japan which will be held at Tokyo Big Sight, Koto
Researchers in the United States, Canada & Europe are testing Colchicine on
Grecobe Cup girls Senior League Cup Knock out Cricket 20.20 Competition will
We have been granted the following Patents for ‘A Single herb extract for the treatment
We are excited to exhibit after a long gap in CPHI Worldwide, Fiera Milano-
It is an immense pleasure to share this news that our Research
We are delighted and proud to announce that our product Reserpine (Rauwolfia
Certificate of Suitability (CEP) for the API Thiocolchicosides has been granted. Chereso
Excited to exhibit after a long due to epidemic & learn what’s
Grecobe Cup girls Senior League Cup Knock out Cricket 20.20 Competition will
[vc_row][vc_column][vc_column_text]We are exhibiting at CPhI Japan will be held at Tokyo Big Sight, Koto
Another feather in a cap! We have been #awarded for ‘Patent portfolio in the
We had exhibited in CPHI– Worldwide, Frankfurt Germany from 5th to 7th November
We had exhibited in CPHI -Japan, 2019 on dated 18-20 March, 2019
We have exhibited at Vitafoods- Geneva, Switzerland, 2019 & continued its successful presence
We are happy to announce that we have received ‘The Extra Mile Award’ from Amazon for
We had exhibited in CPHI- India 2018 at Greater Noida, India. Great place with full of
Furocyst poster presentation ” TO STUDY THE EFFICACY AND SAFETY OF FUROSTANOLIC
Fenfuro abstract title: Clinical study to determine the efficacy of Trigonella foenum-graecum
News coverage by Dainik Jagran for the initiative taken by Chemical Resources-
We had exhibited in CPHI – Worldwide at Faria de Madrid ,
We are proud to share that Chemical Resources(CHERESO) has won Trophy in the
We had exhibited in CPHI Japan from 18-20 April, 2018 at Big Sight Exhibition
We had exhibited in Vitafoods Europe from 15 – 17 May, 2018 at Palexpo, Geneva, Switzerland.
We have participated in Men’s Health Congress 2017 at the Mohammed bin Rashid
Chereso participated in CPHI Worldwide. This proved to be a huge success.
TEAM FENFURO participated in The Arab Health Exhibition and Congress, Dubai from 30th
Our company has been awarded “Nutraceuticals and Herbals Excellence Award 2016” by
We are proud to share that our company has been awarded two national
We won 2nd position in poster presentation at International Conference on PCOS-
We have exhibited in Vitafoods Asiaworld-Expo,Hong Kong on 1-2 September’ 2016 & we
Our Company has been awarded ‘BUSINESS LEADERSHIP AWARD’ by the Indian Achievers
We have organised the CME meet on Furocyst – For PCOS MANAGEMENT on 22nd February
Team FENFURO in association with Dabur Dhanvantry Hospital had organised a free
Our company has been awarded ‘AIMA – Dr. J S Juneja’ for
TEAM FENFURO is participating in Vitafoods Asia 2017. Please visit us at Booth No.
TEAM FENFURO is participating in Vitafoods Europe 2017. Please visit us at Booth
We have exhibited in Vitafoods Asiaworld-Expo,Hong Kong on 1-2 September’ 2016 & we
Poster Presentation on ‘Lowering of Blood Pressure in Diabetic Patients Receiving FENFURO
Enlarged prostate gland is a common problem in the ageing males. It
We are glad to inform that our Company has been awarded OUTSTANDING
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH
Poster Presented on “A Muti-centric placebo-controlled double-blind clinical study to determine the
Team Furocyst had conducted the CME conference of Obs./Gyn. doctors- Mohali Chapter
Abstract has been accepted as a poster presentation- ‘Clinical evaluation of fenugreek
Over 30 lakh diabetes patients across the country were on pioglitazone drug
We are glad to inform that our company has been awarded ‘Asia
Diabetes is a progressive disease; therefore, a single treatment regimen cannot be
TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association
We are glad to inform that our Company has been awarded SME
TEAM FENFURO participated in BPCON 2013 – 23rd annual meeting of Indian
TEAM FENFURO particpated in 32nd Edition of India International Trade Fair (IITF)
TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association
TEAM FENFURO hosted the Continuing Medical Education(CME) meet on DIABESITY which was
Team FENFURO sponsored the musical program titled “Sur-Sangam-12” to salute the legends
Team FENFURO sponsored the musical program titled “Sur-Sangam-12” to salute the legends
News from the American Diabetes Association’s 71st Scientific Sessions An A1C goal
Medication used to treat patients with type II diabetes activates sensors on
Each year, an average of 200,000 Americans are hospitalized because of flu
Diabetes can destroy small blood vessels, which in turn can damage the
Patients with type 2 diabetes treated with insulin could be exposed to
Medicine tied to lower thyroid-stimulating hormone levels in those with underactive thyroid
Diabetes is a progressive disease; therefore, a single treatment regimen cannot be
Washington, Jan 10 : Middle-aged adults who are recently diagnosed with diabetes
Over 30 lakh diabetes patients across the country were on pioglitazone drug
Man-made chemicals in everyday items such as paint, plastics and mattresses may
People who need treating with repeated courses of antibiotics may be at
